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To the Editor: Platelet-activating factor (1-alkyl-2-acetyl glycerophosphocholine; PAF) is a 
lipid-derived mediator with diverse functions (Shimizu, 2009). Glycerophosphocholines 
(GPCs) from cell membranes with unsaturated sn-2 fatty acids can undergo oxidation 
resulting in the formation of oxidized GPCs (Ox-GPCs) which can act as potent agonists for 
the PAF receptor (PAF-R) (Konger et al, 2008). Many environmental pro-oxidative stressors 
from cigarette smoke to ultraviolet B radiation (UVB) can induce systemic 
immunosuppression via generation of Ox-GPC PAF-R ligands (Sahu et al, 2013, 
Walterscheid et al, 2002, Wolf et al, 2006, Yao et al, 2009, Zhang et al, 2008). Of interest, 
UVB-generated PAF-R ligands also augment experimental melanoma tumor growth by 
suppressing anti-tumor immunity in a process involving mast cells and regulatory T cells 
(Damiani and Ullrich, 2016; Sahu et al, 2012).
Recently our group has demonstrated that ethanol (EtOH) exposure results in an 
augmentation of enzymatic PAF synthesis in response to thermal burn injury, in a process 
involving cytosolic phospholipase A2 (Harrison et al., 2018). The present study was 
designed to test the hypothesis that EtOH exposure could generate increased levels of PAF in 
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response to UVB, and that UVB will be more immunosuppressive when EtOH intoxicated. 
This is a relevant concern as the immunosuppressive effects of UVB contribute to (Damiani 
and Ullrich, 2016), and EtOH exposure is linked to an increased incidence of non-melanoma 
skin cancer (Fung et al., 2002; Freedman et al., 2003; Jensen et al., 2012).
First, to evaluate whether ethanol can augment UVB-mediated production of PAF-R ligands, 
we pre-incubated the human keratinocyte-derived cell line HaCaT with 1% EtOH for 30 
min, then treated with 1000 J/m2 UVB using our Philips unit as previously described 
(Marathe et al., 2005; Yao et al, 2009). Ten minutes after UVB treatment, the lipids were 
extracted as previously described (Marathe et al., 2005) using the Bligh & Dyer method 
(Bligh and Dyer, 1959). As multiple glycerophosphocholine species can act as PAF-R 
agonists, we quantified total PAF-R biochemical activity using PAF-R-expressing KBP cells 
that produce IL-8 when the receptor is activated (model in Figure 1a) (Pei et al, 1998; 
Harrison et al., 2018). KBP and PAF-R-negative KBM cells were exposed to lipid extracts 
from HaCaT cells treated with sham, UVB, EtOH alone, or EtOH + UVB and incubated for 
6 hours. The KBP cells were also treated with 1 nM of the metabolically stable PAF-R 
agonist carbamoyl PAF (CPAF) or 0.1% EtOH as vehicle for positive and negative controls. 
As shown in Figure 1b, lipid extracts derived from HaCaT cells treated with EtOH + UVB 
resulted in increased levels of IL-8 release from KBP cells. Yet, this fluence of UVB alone 
resulted in only a minimal level of increased IL-8 release in KBP cells (which was not 
statistically significant), and none of the lipid extracts triggered IL-8 release in PAF-R-
negative KBM cells with 10 nM of the phorbol ester phorbol myristic acetate used as a 
positive control (data not shown). Of interest, structural analysis of PAF-R agonistic activity 
following the combination of EtOH + UVB in HaCaT cells by mass spectrometric analysis 
revealed only enzymatically-generated PAF agonists 1-hexadecyl-2-acetyl GPC and 1-
octadecyl-2-acetyl-GPC, not significant amounts of Ox-GPCs (data not shown), which we 
have described are generated following higher fluences of UVB (Marathe et al., 2005). 
Previously, we have demonstrated that topical application of 20% EtOH to de-identified 
discarded human skin explants derived from surgical contouring procedures (Exempted 
study, Wright State University) 30 minutes before a thermal burn injury results in an 
augmentation of PAF production (Harrison et al., 2018). Using this protocol, we tested if 
topical EtOH pretreatment can increase PAF following UVB treatment. Of importance, we 
used a fluence of UVB (1000 J/m2) that we have previously reported results in only a small 
reproducible increase in PAF activity (Travers et al., 2010). Ten minutes post UVB/sham, 
the epidermis was curetted, weighed and lipids extracted. As shown in Figure 1c, 
pretreatment of skin with EtOH resulted in an exaggerated amount of UVB-generated PAF. 
We next tested if EtOH intoxication can increase the ability of UVB to generate PAF-R 
agonists in murine skin in vivo. These studies used a previously published murine model of 
intraperitoneal injection of 2.4g/kg (approximately 400 μl of 20%) EtOH (Faunce et al., 
1997; Harrison et al., 2018) into anesthetized C57BL6 mice followed 30 minutes later by 
UVB treatment (2500 J/m2) of an area of 2 × 2 cm2 of shaved lower back skin. All animal 
studies were approved by the institutional review boards of Indiana University and Wright 
State University. Ten minutes following sham or UVB treatment, the mice were euthanized, 
and the epidermal skin was removed using a curette and weighed, and lipids extracted. As 
depicted in Figure 1d, lipid extracts from the skin of UVB-treated intoxicated mice 
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generated more PAF-R activity than saline-treated counterparts. Again, none of these lipid 
extracts from human nor murine skin generated IL-8 release in KBM cells (data not shown).
As UVB induces systemic immunosuppression (as measured by inhibition of delayed type 
hypersensitivity reactions to Candida antigen, or contact hypersensitivity reactions to the 
allergen dinitrofluorobenzene [DNFB]) in a PAF-R-dependent manner (Walterscheid et al 
2002; Zhang et al., 2008), our finding that EtOH augmented UVB-induced PAF production 
prompted examination of the ability of EtOH intoxication on UVB-induced systemic 
immunosuppression. To assess the effects of the injury on immune competence, wild-type 
mice received various fluences of UVB (1000–5000 J/m2) 30 minutes following EtOH or 
saline treatment, or control treatments and were then subjected to the well-established 
delayed-type hypersensitivity protocol (Zhang et al., 2008; Sahu et al., 2013). Briefly, 5 days 
after treatments, the mice were sensitized with the chemical DNFB applied topically to the 
shaved non-UVB treated part of the upper back (to assess for systemic immunosuppression) 
and challenged 9 days later with DNFB applied to the ears. The intensity of the immune 
response to DNFB was measured by change in the ear thickness before and 24 hours after 
the delayed challenge. Animals were also injected with various doses of the CPAF or 
histamine as controls for PAF-R dependent and independent immunosuppression, 
respectively. PAFR-deficient mice (Ptafr−/−) mice only received the high dose of 5000J/m2, 
since we have previously reported that these mice do not respond to UVB with systemic 
immunosuppression (Zhang et al., 2008). As shown in Figure 2a, intoxicated wild-type mice 
responded to lower fluences of UVB with decreased elicitation responses to DNFB as 
compared to saline-treated counterparts. Intoxication had no effect alone, nor did it augment 
the immunosuppressive effects of CPAF. In contrast, UVB and CPAF did not exert 
immunosuppressive responses in saline nor EtOH treated Ptafr−/− mice, yet histamine 
treatment resulted in a decreased DNFB response (Figure 2b). Application of DNFB to 
unsensitized wild-type mice only resulted in approximately 10% of the ear thickness 
reactions found in sensitized mice, and addition of EtOH did not modulate this irritant effect 
(data not shown). These studies indicate that EtOH intoxication can augment the 
immunosuppressive effects of UVB through augmented PAF generation.
Alcohol exerts profound effects in humans. The combination of EtOH and UVB is common, 
and studies have described alcohol use as a risk factor for skin cancer (Fung et al., 2002; 
Freedman et al., 2003; Jensen et al., 2012). The present studies demonstrate that EtOH 
exposure can increase PAF synthesis in response to UVB, and that an outcome of this 
clinically relevant combination is augmented UVB-mediated systemic immunosuppression 
leading to increased risks of EtoH-associated morbidity and skin cancer.
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Figure 1: EtOH exposure augments PAF-R agonistic activity in response to UVB in HaCaT cells 
in vitro, human skin ex vivo, and murine skin in vivo.
(a) Model system of KBP-IL-8 assay where a complex mixture (lipid extracts) containing 
PAF agonists are incubated with PAF-R-positive KBP cells or PAF-R negative KBM cells 
and IL-8 released into medium measured as a surrogate for PAF-R activation, using PAF-R 
agonist CPAF as a positive control. (b). HaCaT cells were treated with 1000 J/m2 UVB or 
sham-treated either under normal conditions or following a 30-minute pre-incubation with 
1% EtOH. Ten minutes post-treatment, the lipids were extracted and normalized to 5 × 106 
HaCaT cells. (c) Human skin explants were treated with topical solution of 20% EtOH in 
PBS (100 μl per 2 × 2 cm2 area) for 30 minutes, then treated with sham or 1000 J/m2 UVB 
and 10 minutes post-treatment epidermis harvested, weighed and lipids extracted, and 
normalized to 25mg of skin. (d) The shaved dorsal back skin of groups of 5–6 anesthetized 
C57BL6 mice were subjected to sham or 2500 J/m2 UVB treatment after a 30 minute 
exposure to intraperitoneal PBS or 2.4g/kg EtOH (blue). Ten minutes following sham/UVB 
treatment to mice, the skin was harvested and lipids extracted and normalized to 10mg 
weight of epidermis. The data are: (b) mean ± SE IL-8 production in KBP cells (pg/106 KBP 
cells) from three separate experiments; (c) mean ± SE % control human skin PAF-R 
agonistic activity from four separate experiments; (d) mean ± SD IL-8 production in KBP 
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cells (pg/106 KBP cells) from 5–6 mice in each group. *Denotes statistically significant (P < 
0.05) changes by Student t test using Prism 6.
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Figure 2: Combining EtOH and UVB results in an enhanced inhibition of contact 
hypersensitivity in a PAF-R-dependent manner.
Wild-type (Ptafr+/+) (a) or PAF-R-deficient (Ptafr−/−) (b) mice underwent treatment with 
either vehicle or EtOH, then 30 min later subjected to UVB or Sham treatment. Some mice 
were treated with 250ng CPAF i.p. or 200 μg Histamine (HIS) s.c. as positive controls for 
inhibition of contact hypersensitivity reactions to allergen DNFB (systemic 
immunosuppression). Five days later the mice were sensitized on non-irradiated back skin 
with DNFB, and 9 days later ear elicitation reactions to DNFB were obtained. The data are 
the Mean ± SE % change in ear thickness of the elicitation reactions obtained from sham-
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treated animals at 24 hours using 7–9 mice in each group, totaled from smaller experiments 
using 3 mice per group. *Denotes significant (P <0.05) differences between sham control 
and EtOH exposed by Student t test using Prism 6. Please note only Histamine treatment 
resulted in an inhibition of CHS reactions to DNFB in Ptafr−/− mice.
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